BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 30444586)

  • 1. [Matrix metalloproteinase-9 in plasma of bone marrow aspirates of patients with acute myeloid leukemia and myelodysplastic syndrome].
    Lesnichenko IF; Kostroma II; Gritsaev SV; Chechetkin AV; Abdulkadyrov KM
    Vopr Onkol; 2016; 62(1):101-3. PubMed ID: 30444586
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biological and clinical relevance of matrix metalloproteinases 2 and 9 in acute myeloid leukaemias and myelodysplastic syndromes.
    Travaglino E; Benatti C; Malcovati L; Della Porta MG; Gallì A; Bonetti E; Rosti V; Cazzola M; Invernizzi R
    Eur J Haematol; 2008 Mar; 80(3):216-26. PubMed ID: 18081721
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Matrix metalloproteinase production by bone marrow mononuclear cells from normal individuals and patients with acute and chronic myeloid leukemia or myelodysplastic syndromes.
    Ries C; Loher F; Zang C; Ismair MG; Petrides PE
    Clin Cancer Res; 1999 May; 5(5):1115-24. PubMed ID: 10353746
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Secretion and Expression of Matrix Metalloproteinase-2 and 9 from Bone Marrow Mononuclear Cells in Myelodysplastic Syndrome and Acute Myeloid Leukemia.
    Chaudhary AK; Chaudhary S; Ghosh K; Shanmukaiah C; Nadkarni AH
    Asian Pac J Cancer Prev; 2016; 17(3):1519-29. PubMed ID: 27039800
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Blast counts are lower in the aspirate as compared to trephine biopsy in acute myeloid leukemia and myelodysplastic syndrome expressing CD56.
    Drexler B; Tzankov A; Martinez M; Baerlocher S; Passweg JR; Dirnhofer S; Tsakiris DA; Dirks J
    Int J Lab Hematol; 2021 Oct; 43(5):1078-1084. PubMed ID: 33709561
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Effects of Human BDH2 on the Cell Cycle, Differentiation, and Apoptosis and Associations with Leukemia Transformation in Myelodysplastic Syndrome.
    Yang WC; Lin SF; Wang SC; Tsai WC; Wu CC; Wu SC
    Int J Mol Sci; 2020 Apr; 21(9):. PubMed ID: 32344823
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High Expression of Human Homologue of Murine Double Minute 4 and the Short Splicing Variant, HDM4-S, in Bone Marrow in Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome.
    Han X; Medeiros LJ; Zhang YH; You MJ; Andreeff M; Konopleva M; Bueso-Ramos CE
    Clin Lymphoma Myeloma Leuk; 2016 Aug; 16 Suppl():S30-8. PubMed ID: 27155969
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of immunohistochemical markers in bone marrow sections to evaluate for myelodysplastic syndromes and acute myeloid leukemias.
    Dunphy CH; O'Malley DP; Perkins SL; Chang CC
    Appl Immunohistochem Mol Morphol; 2007 Jun; 15(2):154-9. PubMed ID: 17525626
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunohistochemical detection of p53, mdm2, waf1/p21, and Ki67 proteins in bone marrow biopsies in myelodysplastic syndroms, acute myelogenous leukaemias and chronic myeloproliferative disorders.
    Kanavaros P; Stefanaki K; Rontogianni D; Darivianaki K; Vlychou M; Papadaki E; Eliopoulos G; Bakiri M; Matsouka C; Kakolyris S; Georgoulias V
    Clin Exp Pathol; 1999; 47(5):231-8. PubMed ID: 10598372
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Marrow cytokine transcripts and the secondary hematologic disorders.
    Preisler HD; Gao XZ; Ming T; Li B; Bi S; Devemy E; Loew J; Raza A
    Leuk Lymphoma; 1999 Oct; 35(3-4):297-302. PubMed ID: 10706453
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Histopathology in the diagnosis and classification of acute myeloid leukemia, myelodysplastic syndromes, and myelodysplastic/myeloproliferative diseases.
    Orazi A
    Pathobiology; 2007; 74(2):97-114. PubMed ID: 17587881
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High levels of Ca(2+)-independent endonuclease activity capable of producing nucleosomal-size DNA fragmentation in non-adherent marrow mononuclear cells from patients with myelodysplastic syndromes and acute myelogenous leukemia.
    Kawabata H; Anzai N; Ueda Y; Masutani H; Hirama T; Yoshida Y; Okuma M
    Leukemia; 1996 Jan; 10(1):67-73. PubMed ID: 8558941
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Telomerase activity in myelodysplastic syndromes.
    Gürkan E; Tanriverdi K; Başlamişli F
    Leuk Res; 2005 Oct; 29(10):1131-9. PubMed ID: 16111531
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Apoptosis, bcl-2 expression and p53 accumulation in myelodysplastic syndrome, myelodysplastic-syndrome-derived acute myelogenous leukemia and de novo acute myelogenous leukemia.
    Kurotaki H; Tsushima Y; Nagai K; Yagihashi S
    Acta Haematol; 2000; 102(3):115-23. PubMed ID: 10692673
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dysplastic erythroid precursors in the myelodysplastic syndromes and the acute myeloid leukemias: Is there biologic significance? (How should blasts be counted?).
    Bennett JM; Tuechler H; Aul C; Strupp C; Germing U
    Leuk Res; 2016 Aug; 47():63-9. PubMed ID: 27258735
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Activity of matrix metalloproteinases MMP-2 and MMP-9 in bone marrow plasma of patients with acute myeloid leukemia].
    Lesnichenko IF; Gritsaev SV; Sergeev AN; Kostroma II; Tiranova SA
    Biomed Khim; 2013; 59(5):578-84. PubMed ID: 24479348
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Context Matters: Distinct Disease Outcomes as a Result of Crebbp Hemizygosity in Different Mouse Bone Marrow Compartments.
    Zhou T; Perez SN; Cheng Z; Kinney MC; Lemieux ME; Scott LM; Rebel VI
    PLoS One; 2016; 11(7):e0158649. PubMed ID: 27427906
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bone marrow cellularity in myeloid stem cell disorders: impact of age correction.
    Tuzuner N; Cox C; Rowe JM; Bennett JM
    Leuk Res; 1994 Aug; 18(8):559-64. PubMed ID: 8065157
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical activity and safety of the dual pathway inhibitor rigosertib for higher risk myelodysplastic syndromes following DNA methyltransferase inhibitor therapy.
    Silverman LR; Greenberg P; Raza A; Olnes MJ; Holland JF; Reddy P; Maniar M; Wilhelm F
    Hematol Oncol; 2015 Jun; 33(2):57-66. PubMed ID: 24777753
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In situ cell cycle kinetics in bone marrow biopsies following sequential infusions of IUdR/BrdU in patients with hematopoietic malignancies.
    Raza A; Yousuf N; Bohkari SA; Sheikh Y; Akhtar S; Chughtai S; Umerani A; Mehdi SA; Miller MA; Masterson M
    Leuk Res; 1992; 16(3):299-306. PubMed ID: 1560677
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.